Engleman Edgar
Bolt Biotherapeutics, Inc. · Director
Engleman Edgar serves as a Director at Bolt Biotherapeutics, Inc., a company focused on innovative therapeutic solutions in the healthcare sector. His recent trading activity includes a series of sales, reflecting a consistent pattern of divestment over the reported period. From November 20, 2023, to December 1, 2023, Edgar executed 12 sales, with the largest transaction valued at approximately $92.8K.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $21k22.7k shares | SellNov 29, 2023 | $0.906 | $4.42 | |
| $2.8k3.1k shares | SellNov 29, 2023 | $0.906 | $4.42 | |
| $1.5k1.7k shares | SellNov 21, 2023 | $0.9014 | $4.42 | |
| $213236 shares | SellNov 21, 2023 | $0.9014 | $4.42 | |
| $25k27.5k shares | SellNov 20, 2023 | $0.92 | $4.42 | |
| $3.5k3.8k shares | SellNov 20, 2023 | $0.92 | $4.42 | |
| $7.6k8.2k shares | SellNov 17, 2023 | $0.93 | $4.42 | |
| $1.1k1.1k shares | SellNov 17, 2023 | $0.93 | $4.42 | |
| $7.2k7.5k shares | SellNov 16, 2023 | $0.96 | $4.42 | |
| $9981k shares | SellNov 16, 2023 | $0.96 | $4.42 |